Item 7.01 Regulation FD Disclosure.

On September 13, 2022, Better Therapeutics, Inc. (the "Company") presented a corporate presentation at the H.C. Wainwright 24th Annual Global Investment Conference. A copy of the corporate presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K. The corporate presentation will also be available on the Company's website in the Investors section at https://investors.bettertx.com/news-events/events-presentations.

The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.

Exhibit
Number       Description

99.1           Corporate Presentation of Better Therapeutics, Inc., dated
             September 13, 2022.

104          Cover Page Interactive Data File (embedded within the Inline XBRL
             document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses